Leavitt sees room for compromise on SCHIP GlaxoSmithKline Picks new CEO FluMist may be used in $2.5 billion federal program NIH funds study on patient comliance Cardinal begins construction on Dublin headquarters Eli Lilly updates product labels Teva releases generic Coreg Caraco receives tentative FDA approval for generic Zyrtec Amgen cancels plans of billion-dollar factory in Ireland Ranbaxy to form separate R&D company First Previous 2666 2667 2668 2669 2670 Next Last